ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.60715
-0.44%
Brent Oil
83.745
0.65%
Bitcoin
66,908.00
2.56%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Merck KGaA (PK) (MKKGY)

  7. Merck KGaA (PK) (MKKGY) Noticias

MKKGY

Merck KGaA (PK) (MKKGY)

Merck KGaA (PK)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:MKKGY
FechaHoraFuenteTítuloSímboloCompañía
06/12/202307:20Dow Jones NewsTrending: Merck's Multiple Sclerosis Drug Misses Expectations in Late-Stage TrialsUSOTC:MKKGYMerck KGaA (PK)
06/12/202304:14Dow Jones NewsMerck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage TrialsUSOTC:MKKGYMerck KGaA (PK)
06/12/202300:37Dow Jones NewsMerck MS Drug Fails to Meet Target of Late-Stage TrialsUSOTC:MKKGYMerck KGaA (PK)
04/12/202308:09Dow Jones NewsMerck to Pay at Least $70 Million for Rights to Abbisko Joint-Tumor DrugUSOTC:MKKGYMerck KGaA (PK)
09/11/202300:54Dow Jones NewsMerck KGaA Sees Earnings, Sales at Lower Half of Outlook RangesUSOTC:MKKGYMerck KGaA (PK)
06/11/202305:20Dow Jones NewsMerck KGaA Weighs Job Cuts at Electronics Division on Market DownturnUSOTC:MKKGYMerck KGaA (PK)
30/10/202303:59Dow Jones NewsMerck KGaA Enters Partnership With China's Hengrui for Up to $1.5 BillionUSOTC:MKKGYMerck KGaA (PK)
19/10/202303:22Dow Jones NewsMerck KGaA Shares Jump on Expected Return to Sales Growth in 2024USOTC:MKKGYMerck KGaA (PK)
19/10/202301:50Dow Jones NewsMerck KGaA Sees Return to Organic Sales Growth Next YearUSOTC:MKKGYMerck KGaA (PK)
20/09/202305:47Dow Jones NewsExscientia Shares Rally Premarket on Lucrative Merck DealUSOTC:MKKGYMerck KGaA (PK)
20/09/202301:05Dow Jones NewsMerck KGaA Enters Deal With BenevolentAI, Exscientia for AI-Based Drug DiscoveryUSOTC:MKKGYMerck KGaA (PK)
03/08/202300:55Dow Jones NewsMerck KGaA Cuts 2023 Outlook on Inventory, Semiconductor WoesUSOTC:MKKGYMerck KGaA (PK)
11/05/202300:46Dow Jones NewsMerck KgaA 1Q Earnings Hit by Lower Covid-19 Demand, Decline at Display SolutionsUSOTC:MKKGYMerck KGaA (PK)
08/05/202306:49Dow Jones NewsMerck KGaA Appoints Helene von Roeder as New CFOUSOTC:MKKGYMerck KGaA (PK)
13/04/202308:41Dow Jones NewsMerck KGaA Planning Sale of Surface Solutions Business, WirtschaftsWoche ReportsUSOTC:MKKGYMerck KGaA (PK)
12/04/202305:51Dow Jones NewsMerck KGaA to Invest $327 Million in Pennsylvania Site ExpansionUSOTC:MKKGYMerck KGaA (PK)
12/04/202302:54Dow Jones NewsMerck KGaA Shares Fall After US Puts Hold on New Patients in MS Drug TrialUSOTC:MKKGYMerck KGaA (PK)
02/03/202303:50Dow Jones NewsMerck KGaA Shares Fall After Warning of Challenges AheadUSOTC:MKKGYMerck KGaA (PK)
02/03/202300:44Dow Jones NewsMerck KGaA Sees Challenging 2023 After Rises in 2022 Earnings, SalesUSOTC:MKKGYMerck KGaA (PK)
21/11/202218:18Dow Jones NewsADRs End Mostly Lower, Naspers and Merck Trade ActivelyUSOTC:MKKGYMerck KGaA (PK)
21/11/202207:03Dow Jones NewsMerck KGaA Says It Plans One New Drug Launch Every One and a Half YearsUSOTC:MKKGYMerck KGaA (PK)
10/11/202201:04Dow Jones NewsMerck KGaA 3Q Sales, Earnings Rose; Fine-Tunes 2022 OutlookUSOTC:MKKGYMerck KGaA (PK)
19/10/202208:58Dow Jones NewsMerck KGaA's French Subsidiary Indicted in France Over Drug Formulation ChangeUSOTC:MKKGYMerck KGaA (PK)
19/10/202204:32Dow Jones NewsMerck KGaA's French Unit Under Further Investigations, AFP ReportsUSOTC:MKKGYMerck KGaA (PK)
06/10/202201:55Dow Jones NewsMerck KGaA Backs Mid-Term Targets; Plans Acquisitions as of 2023USOTC:MKKGYMerck KGaA (PK)
04/08/202201:06Dow Jones NewsMerck KGaA Earnings, Sales Grew in 2QUSOTC:MKKGYMerck KGaA (PK)
03/06/202209:21Dow Jones NewsMerck KGaA Discontinues Phase 2 Trial of Berzosertib in Combination With TopotecanUSOTC:MKKGYMerck KGaA (PK)
02/06/202211:38Dow Jones NewsProxygen Teams With Merck KGaA to Develop Molecular Glue DegradersUSOTC:MKKGYMerck KGaA (PK)
23/05/202204:53Dow Jones NewsMerck KGaA to Invest Around $465 Million to Expand Operations in IrelandUSOTC:MKKGYMerck KGaA (PK)
12/05/202200:31Dow Jones NewsMerck KGaA Expects Higher Profitability, Sales in 2022 After 1Q Earnings RiseUSOTC:MKKGYMerck KGaA (PK)
 Showing the most relevant articles for your search:USOTC:MKKGY

Su Consulta Reciente

LSE
UOG
United Oil & Gas
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados